Patent
The present invention relates to novel peptides that may be used in whole or in combination for the detection of Mycobacterium tuberculosis infection. In particular, the present invention relates to compositions and methods involving detection of antibodies contained in the blood of non-human primates that arise from an infection from M. tuberculosis or vaccination using an epitope specific inoculation. More particularly, the present invention provides a means to distinguish early, active, and latent M. tuberculosis infection. More particularly, the present invention describes an immunological diagnostic mechanism for the detection of M. tuberculosis infection.
1. An immunoassay device comprising a capture reagent immobilized on a surface of the device, said capture reagent comprising base peptide SEQ ID NO:139 and up to five amino acids on either or both of the amino- or carboxy-terminus of the base peptide.
2. The immunoassay device of claim 1 , wherein said device comprises at least one additional capture reagents comprising a peptide selected from the group consisting of SEQ ID NOs.141, 145, 147, 98 and 56.